Latham & Watkins LLP is well-known in the market for handling complex IP transactions, including cross-licensing, collaboration, and joint agreements, as well as due diligence relating to the licensing of IP. The team chiefly handles licenses relating to the life sciences and technology sectors, fielding dedicated teams maintaining close relationships with clients in these spaces. Key members of the team are Christopher Hazuka in San Diego, who advises life sciences companies on agreements and transactions, Aaron Gardner in New York, who focuses on the biotech and nutrition spaces, and Jengeun Jekkie Kim in the Bay Area, who handles licensing and commercial transactions in connection with digital health products and medical devices. Judith Hasko has left the firm.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
- 'I was really impressed with Aaron Gardner. Aaron has very comprehensive expertise in life sciences industry, so even though we worked on a licensing deal, his M&A experiences came in really handy on complex issues. He is a senior partner but can still draft on the fly (to the details of flawless section references and formatting) while negotiating and providing high-level strategic advice on the deal. Aaron is absolutely one of the top advisors.'
Key clients
- Shape Therapeutics
- Sonoma Biotherapeutics
- Scleroderma Research Foundation
- CytomX
- 4D Molecular Therapeutics (4DMT)
- Endeavor BioMedicines
- Sanofi
- Erasca, Inc.
- Nielsen BioSciences, Inc.
- Zentalis Pharmaceuticals, Inc.
Lawyers
Next generation partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Judith Hasko
Other key lawyers
Christopher Hazuka; Aaron Gardner; Jungeun Jekkie Kim